This study proves the concept that inducing HMGCR degradation can effectively reduce serum cholesterol levels and overcome the defect of statins (Fig. 7), highlighting a promising strategy for treating hypercholesterolemia and CVDs. The gene discussed is HMGCR; the disease is Hypercholesterolemia.